Metabolomic analysis of two leukemia cell lines. II.
Pharmaceutical Intelligence,
Metabolomic analysis of two leukemia cell lines. II. Larry H. Bernstein, MD, FCAP, Reviewer and Curator Leaders in…
Metabolomic analysis of two leukemia cell lines. II. Larry H. Bernstein, MD, FCAP, Reviewer and Curator Leaders in…
The main meeting last week was my final one of the Research Councils’ Chief Executives Group. We often have discussions with…
In November last year, the 7th National Cancer Research Institute (NCRI) Cancer Conference was held in Liverpool, UK. This…
HLRCC, caused by mutations in FH, predisposes patients to develop papillary renal cell carcinoma. FH-deficient cells have an…